BDBM476507 (2S)-4-[(4S,5S)-4-methyl-5-phenyl- 4,5-dihydro-1,3-oxazol-2-yl]-1-(6- piperidin-1-yl-D-norleucyl)-N- (thieno[3,2-c]pyridin-2- ylmethyl)piperazine-2-carboxamide::US10875851, Example 163

SMILES C[C@@H]1N=C(N2CCN(C(=O)[C@H](N)CCCCN3CCCCC3)[C@H](C(=O)NCc3cc4cnccc4s3)C2)O[C@H]1c1ccccc1

InChI Key InChIKey=LSBYZXOOCPWNQL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 476507   

TargetCoagulation factor XII(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 476507BDBM476507((2S)-4-[(4S,5S)-4-methyl-5-phenyl- 4,5-dihydro-1,3...)
Affinity DataIC50: 15nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of Coagulation Factor XIIa can be determined using a relevant purified serin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
US Patent